Literature DB >> 10956321

ACE inhibition and AT(1) receptor blockers: efficacy and duration in hypertension.

P A Meredith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956321      PMCID： PMC1766526          DOI： 10.1136/heart.84.suppl_1.i39

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  Blood-pressure control in the hypertensive population.

Authors:  G Mancia; R Sega; C Milesi; G Cesana; A Zanchetti
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

2.  Prediction of the antihypertensive response to enalapril.

Authors:  P A Meredith; R Donnelly; H L Elliott; C A Howie; J L Reid
Journal:  J Hypertens       Date:  1990-12       Impact factor: 4.844

3.  The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan.

Authors:  O K Andersson; S Neldam
Journal:  Blood Press       Date:  1998-01       Impact factor: 2.835

4.  Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.

Authors:  H J Heuer; G Schöndorfer; A M Högemann
Journal:  J Hum Hypertens       Date:  1997-09       Impact factor: 3.012

5.  A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.

Authors:  Y Lacourcière; R Asmar
Journal:  Am J Hypertens       Date:  1999-12       Impact factor: 2.689

Review 6.  Blood pressure variability and its implications for antihypertensive therapy.

Authors:  P A Meredith; D Perloff; G Mancia; T Pickering
Journal:  Blood Press       Date:  1995-01       Impact factor: 2.835

7.  Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring.

Authors:  M Diamant; H H Vincent
Journal:  J Hum Hypertens       Date:  1999-06       Impact factor: 3.012

8.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.

Authors:  G Mancia; A Zanchetti; E Agabiti-Rosei; G Benemio; R De Cesaris; R Fogari; A Pessina; C Porcellati; A Rappelli; A Salvetti; B Trimarco; E Agebiti-Rosei; A Pessino
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

Review 9.  Trough:peak ratio of the blood pressure response to angiotensin converting enzyme inhibitors.

Authors:  A Salvetti; L Di Venanzio; P Arrighi; F Arzilli
Journal:  J Hypertens Suppl       Date:  1994-11
  9 in total
  1 in total

Review 1.  Benefits of once-daily therapies in the treatment of hypertension.

Authors:  John M Flack; Samar A Nasser
Journal:  Vasc Health Risk Manag       Date:  2011-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.